Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Neeta Singla"'
Autor:
Yasir Alvi, Sairu Philip, Tanu Anand, Palanivel Chinnakali, Farzana Islam, Neeta Singla, Pruthu Thekkur, Ashwani Khanna, BK Vashishat
Publikováno v:
Tropical Medicine and Infectious Disease, Vol 9, Iss 1, p 24 (2024)
Tuberculosis Preventive Treatment (TPT) is a powerful tool for preventing the TB infection from developing into active TB disease, and has recently been expanded to all household contacts of TB cases in India. This study employs a mixed-methods appro
Externí odkaz:
https://doaj.org/article/2572d701fc0f4a5f994db53f91619632
Autor:
Palak Mahajan, Kathirvel Soundappan, Neeta Singla, Kedar Mehta, Amenla Nuken, Pruthu Thekkur, Divya Nair, Sampan Rattan, Chaturanand Thakur, Kuldeep Singh Sachdeva, Bharati Kalottee
Publikováno v:
Tropical Medicine and Infectious Disease, Vol 9, Iss 1, p 7 (2023)
Tuberculosis preventive treatment (TPT) is an important intervention in preventing infection and reducing TB incidence among household contacts (HHCs). A mixed-methods study was conducted to assess the “Test and Treat” model of TPT care cascade a
Externí odkaz:
https://doaj.org/article/f4420054a7ed4e78895199bb8cc5d0d3
Autor:
U. C. Samudyatha, Kathirvel Soundappan, Gomathi Ramaswamy, Kedar Mehta, Chandan Kumar, M. Jagadeesh, B. T. Prasanna Kamath, Neeta Singla, Pruthu Thekkur
Publikováno v:
Tropical Medicine and Infectious Disease, Vol 8, Iss 12, p 512 (2023)
The National TB Elimination Programme (NTEP) of India is implementing tuberculosis preventive treatment (TPT) for all household contacts (HHCs) of pulmonary tuberculosis patients (index patients) aged 5 years with TB infection (TBI). We conducted an
Externí odkaz:
https://doaj.org/article/8170b060a68c45bb9b17ff581737ebe2
Autor:
Kiran B, Rupak Singla, Neeta Singla, Vinay V, Kuljeet Singh, Madhumita Paul Choudhury, Nilotpal Bhattacherjee
Publikováno v:
Monaldi Archives for Chest Disease (2022)
Rifampicin-resistant/multidrug-resistant tuberculosis (RR/MDR-TB) is a significant burden on global tuberculosis (TB) prevention and eradication efforts. MDR-TB can be treated, but it is expensive, takes a long time (typically two years), and contain
Externí odkaz:
https://doaj.org/article/49e5e7c7bab6411397606d6c23859d31
Publikováno v:
Lung India, Vol 35, Iss 1, Pp 4-8 (2018)
Background: Treatment of multidrug-resistant (MDR-TB) mainly focuses on bacteriological cure. However, only limited studies have evaluated the sequelae left after the completion of treatment among MDR-TB patients. Objective: To assess the persistent
Externí odkaz:
https://doaj.org/article/07e951bb172c43d4ba693f9cd440a616
Autor:
Surendra K. Sharma, Kiran Katoch, Rohit Sarin, Raman Balambal, Nirmal Kumar Jain, Naresh Patel, Kolluri J. R. Murthy, Neeta Singla, P. K. Saha, Ashwani Khanna, Urvashi Singh, Sanjiv Kumar, A. Sengupta, J. N. Banavaliker, D. S. Chauhan, Shailendra Sachan, Mohammad Wasim, Sanjay Tripathi, Nilesh Dutt, Nitin Jain, Nalin Joshi, Sita Ram Raju Penmesta, Sumanlatha Gaddam, Sanjay Gupta, Bakulesh Khamar, Bindu Dey, Dipendra K. Mitra, Sunil K. Arora, Sangeeta Bhaskar, Rajni Rani
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
Abstract Prolonged treatment of tuberculosis (TB) often leads to poor compliance, default and relapse, converting primary TB patients into category II TB (Cat IITB) cases, many of whom may convert to multi-drug resistant TB (MDR-TB). We have evaluate
Externí odkaz:
https://doaj.org/article/6a0b4f888de74d3abacaae3ac171d9ed
Autor:
Banurekha Velayutham, Vineet Kumar Chadha, Neeta Singla, Pratibha Narang, Vikas Gangadhar Rao, Sanjeev Nair, Srinivasan Ramalingam, Gomathi Narayanan Sivaramakrishnan, Bency Joseph, Sriram Selvaraju, Shivakumar Shanmugam, Rahul Narang, Praseeja Pachikkaran, Jyothi Bhat, Chinnaiyan Ponnuraja, Bhoomika Bajaj Bhalla, Bhadravathi Amarnath Shivashankara, George Sebastian, Rajiv Yadav, Ravendra Kumar Sharma, Rohit Sarin, Vithal Prasad Myneedu, Rupak Singla, Khalidumer Khayyam, Sunil Kumar Mrithunjayan, Subramonia Pillai Jayasankar, Praveen Sanker, Krishnaveni Viswanathan, Rajeevan Viswambharan, Kapil Mathuria, Manpreet Bhalla, Nitu Singh, Kondeshvar Balaji Tumane, Ajay Dawale, Chandra Prakash Tiwari, Radhelal Bansod, Lavanya Jayabal, Lakshmi Murali, Sunil D Khaparde, Raghuram Rao, Mohideen S Jawahar, Mohan Natrajan
Publikováno v:
PLoS ONE, Vol 13, Iss 7, p e0200150 (2018)
INTRODUCTION:There is lack of information on the proportion of new smear-positive pulmonary tuberculosis (PTB) patients treated with a 6-month thrice-weekly regimen under Revised National Tuberculosis Control Programme (RNTCP) who develop recurrent T
Externí odkaz:
https://doaj.org/article/1fceb7575ad842b3b143dcbb6d558787
Autor:
Rupak Singla, Sanjay Kumar Bharty, Uday Aditya Gupta, Khalid Umar Khayyam, Vikram Vohra, Neeta Singla, Vithal Prasad Myneedu, Digambar Behera
Publikováno v:
International Journal of Mycobacteriology, Vol 2, Iss 4, Pp 199-205 (2013)
Background and Objectives: In pulmonary tuberculosis, bacteriological status at two months affects subsequent treatment and prognosis. The effect on treatment outcome and risk factors for sputum conversion at two months treatment in previously untrea
Externí odkaz:
https://doaj.org/article/a81bbb6945df4736864203bec3940690
Autor:
Katherine Floyd, VK Arora, KJR Murthy, Knut Lonnroth, Neeta Singla, Y Akbar, Matteo Zignol, Mukund Uplekar
Publikováno v:
Bulletin of the World Health Organization, Vol 84, Iss 6, Pp 437-445 (2006)
OBJECTIVE: To assess the cost and cost-effectiveness of the Public-Private Mix DOTS (PPM-DOTS) strategy for tuberculosis (TB) ontrol in India. METHODS: We collected data on the costs and effects of pilot PPM-DOTS projects in Delhi and Hyderabad using
Externí odkaz:
https://doaj.org/article/c681a10fd4ed4100ab1ce81d6fe363cb
Autor:
Neeta Singla, Srinath Satyanarayana, Kuldeep Singh Sachdeva, Rafael Van den Bergh, Tony Reid, Katherine Tayler-Smith, V P Myneedu, Engy Ali, Donald A Enarson, Digamber Behera, Rohit Sarin
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e102989 (2014)
SETTING: National Institute of Tuberculosis and Respiratory Diseases (erstwhile Lala Ram Sarup Institute) in Delhi, India. OBJECTIVES: To evaluate before and after the introduction of the line Probe Assay (LPA) a) the overall time to MDR-TB diagnosis
Externí odkaz:
https://doaj.org/article/547c753c123a4f8880577b7a425bcbdc